{
    "2018-06-29": [
        [
            {
                "time": "2018-06-29",
                "original_text": "豪哥观点：外资狂捡筹码，我们却在割肉",
                "features": {
                    "keywords": [
                        "外资",
                        "捡筹码",
                        "割肉"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "[强于大市评级] 深度*行业*医药生物行业2018年中期策略：调整之后板块出现战略性买入机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中期策略",
                        "买入机会"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "[优异评级] 医药生物行业2018半年度策略：医改落地 机会绽放",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医改",
                        "机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "进口创新药落地加速，本土药企的“中国芯”将如何炼成？",
                "features": {
                    "keywords": [
                        "创新药",
                        "本土药企",
                        "中国芯"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "处方外流市场争夺硝烟渐起 阿里健康收购玉平民大药房",
                "features": {
                    "keywords": [
                        "处方外流",
                        "阿里健康",
                        "收购"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "电商"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "[推荐评级] 创新药产业深度报告暨2018年中期投资策略：医药创新的收获期逐渐来临",
                "features": {
                    "keywords": [
                        "创新药",
                        "医药创新",
                        "收获期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "头个中国自主研发生产抗癌药将上市 关注国内抗癌药上市公司",
                "features": {
                    "keywords": [
                        "抗癌药",
                        "自主研发",
                        "上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "华大基因：员工没有活到100岁，股价先跌破100了 | 功夫论市",
                "features": {
                    "keywords": [
                        "华大基因",
                        "股价",
                        "跌破"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "全球资金流向监测：资金避险入债；美股大幅流出，新兴港股流出继续",
                "features": {
                    "keywords": [
                        "资金流向",
                        "避险",
                        "流出"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "全球市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-29",
                "original_text": "[推荐评级] 医药行业周报：回调不改长期逻辑 把握业绩确定性",
                "features": {
                    "keywords": [
                        "医药行业",
                        "回调",
                        "业绩确定性"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}